{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:54:05Z","timestamp":1786136045195,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jfma.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:55:28Z","timestamp":1786049728000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term effect of AST-120 on delaying renal replacement therapy initiation in CKD: A propensity score overlap-weighted retrospective cohort study"],"prefix":"10.1016","author":[{"given":"Chin-Te","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9400-8180","authenticated-orcid":false,"given":"Tong-Jia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6824-4819","authenticated-orcid":false,"given":"Chyong-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Kai","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-5613","authenticated-orcid":false,"given":"Ann Charis","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-8212","authenticated-orcid":false,"given":"Szu-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-3159","authenticated-orcid":false,"given":"Chih-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-2612","authenticated-orcid":false,"given":"Fan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-3561","authenticated-orcid":false,"given":"Chih-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10518","key":"10.1016\/j.jfma.2026.08.003_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jfma.2026.08.003_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.0000000892","article-title":"National prevalence, regional distribution, and risk factors for CKD in Taiwan","volume":"21","author":"Ang","year":"2026","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.003_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/nep.70055","article-title":"Projection of the Prevalence and economic burden of chronic kidney disease in Taiwan from 2022 to 2027 (Inside CKD): a microsimulation study","volume":"30","author":"Wu","year":"2025","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1016\/j.jfma.2026.08.003_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.jfma.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(16)00033-4","article-title":"Clinical management of the uraemic syndrome in chronic kidney disease","volume":"4","author":"Vanholder","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"10.1016\/j.jfma.2026.08.003_bib6","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurheartj\/ehaa1049","article-title":"The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart","volume":"42","author":"Chan","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jfma.2026.08.003_bib7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of AST-120 in CKD","volume":"26","author":"Schulman","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jfma.2026.08.003_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2215\/CJN.12011214","article-title":"A randomized, controlled trial of oral intestinal sorbent AST-120 on renal function deterioration in patients with advanced renal dysfunction","volume":"11","author":"Cha","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jfma.2026.08.003_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10157-017-1447-0","article-title":"Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120","volume":"22","author":"Schulman","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.23876\/j.krcp.2017.36.1.68","article-title":"Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin study against renal disease progression in Korea","volume":"36","author":"Cha","year":"2017","journal-title":"Kidney Res Clin Pract"},{"issue":"1\u20132","key":"10.1016\/j.jfma.2026.08.003_bib11","first-page":"1","article-title":"Uremic toxicity of indoxyl sulfate","volume":"72","author":"Niwa","year":"2010","journal-title":"Nagoya J Med Sci"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.003_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2026.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676345","article-title":"Efficacy of AST-120 for patients with chronic kidney disease: a network meta-analysis of randomized controlled trials","volume":"12","author":"Su","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.jfma.2026.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101718","article-title":"Effects and safety of an oral adsorbent on chronic kidney disease progression: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12882-016-0357-9","article-title":"The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials","volume":"17","author":"Schulman","year":"2016","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.jfma.2026.08.003_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2020.02.141","article-title":"Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition","volume":"525","author":"Sato","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.003_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41598-024-51498-6","article-title":"Effects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis","volume":"14","author":"Lee","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jfma.2026.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12110684","article-title":"Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease","volume":"12","author":"Cheng","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.jfma.2026.08.003_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabres.2008.04.024","article-title":"AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects","volume":"81","author":"Konishi","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jfma.2026.08.003_bib20","article-title":"Indoxyl-sulfate-induced redox imbalance in chronic kidney disease","volume":"10","author":"Lu","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/j.jfma.2026.08.003_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16120544","article-title":"The ability of AST-120 to lower the serum indoxyl sulfate level improves renal outcomes and the lipid profile in diabetic and nondiabetic animal models of chronic kidney disease: a meta-analysis","volume":"16","author":"Altunkaynak","year":"2024","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.jfma.2026.08.003_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1442-2042.2004.00989.x","article-title":"Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study","volume":"12","author":"Takahashi","year":"2005","journal-title":"Int J Urol"},{"issue":"12","key":"10.1016\/j.jfma.2026.08.003_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jfma.2026.08.003_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:07:31Z","timestamp":1786133251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"alternative-id":["S0929664626007734"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effect of AST-120 on delaying renal replacement therapy initiation in CKD: A propensity score overlap-weighted retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}